Related references
Note: Only part of the references are listed.The Role of Radiolabeled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for the Evaluation of Renal Cancer
Laura Evangelista et al.
EUROPEAN UROLOGY FOCUS (2020)
Inconsistent Detection of Sites of Metastatic Non-Clear Cell Renal Cell Carcinoma with PSMA-Targeted [18F]DCFPyL PET/CT
Yafu Yin et al.
MOLECULAR IMAGING AND BIOLOGY (2019)
Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives
Philipp Backhaus et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms
Roberto A. Salas Fragomeni et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Comprehensive Evaluation of Prostate Specific Membrane Antigen Expression in the Vasculature of Renal Tumors: Implications for Imaging Studies and Prognostic Role
Sophia Spatz et al.
JOURNAL OF UROLOGY (2018)
68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review
Julia Corfield et al.
WORLD JOURNAL OF UROLOGY (2018)
Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Locally Advanced, Recurrent, and Metastatic Prostate Cancer
Marlon Perera et al.
JAMA ONCOLOGY (2018)
Diagnostic potential of PET/CT using a 68Ga-labelled prostate-specific membrane antigen ligand in whole-body staging of renal cell carcinoma: initial experience
Lino M. Sawicki et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
PSMA-Targeted 18F-DCFPyL PET/CT Imaging of Clear Cell Renal Cell Carcinoma: Results from a Rapid Autopsy
Michael A. Gorin et al.
EUROPEAN UROLOGY (2017)
Utility of 68Ga prostate specific membrane antigen - positron emission tomography in diagnosis and response assessment of recurrent renal cell carcinoma
Shankar Siva et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2017)
Systemic Therapy for Metastatic Renal-Cell Carcinoma
Toni K. Choueiri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Incidental Malignancies Identified During Staging for Prostate Cancer With 68Ga Prostate-specific Membrane Antigen HBED-CC Positron Emission Tomography Imaging
Andre Joshi et al.
UROLOGY (2017)
68Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends
Cristian Udovicich et al.
PROSTATE INTERNATIONAL (2017)
Evaluation of Practical Interpretation Hurdles in 68Ga-PSMA PET/CT in 55 Patients Physiological Tracer Distribution and Incidental Tracer Uptake
Julian Kirchner et al.
CLINICAL NUCLEAR MEDICINE (2017)
68Ga-PSMA-HBED-CC PET for Differential Diagnosis of Suggestive Lung Lesions in Patients with Prostate Cancer
Thomas Pyka et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
68Ga Prostate-Specific Membrane Antigen Uptake in Renal Cell Cancer Lymph Node Metastases
Ingo Einspieler et al.
CLINICAL NUCLEAR MEDICINE (2016)
Complimentary Pattern of Uptake in 18F-FDG PET/CT and 68Ga-Prostate-Specific Membrane Antigen PET/CT in a Case of Metastatic Clear Cell Renal Carcinoma
Arun Sasikumar et al.
CLINICAL NUCLEAR MEDICINE (2016)
Detection of F-18-FDG PET/CT Occult Lesions With F-18-DCFPyL PET/CT in a Patient With Metastatic Renal Cell Carcinoma
Steven P. Rowe et al.
CLINICAL NUCLEAR MEDICINE (2016)
Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis
Marlon Perera et al.
EUROPEAN UROLOGY (2016)
177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy
Richard P. Baum et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer
H. Rhee et al.
JOURNAL OF UROLOGY (2016)
Management of Renal Masses and Localized Renal Cancer: Systematic Review and Meta-Analysis
Phillip M. Pierorazio et al.
JOURNAL OF UROLOGY (2016)
Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced disease
Handoo Rhee et al.
PATHOLOGY (2016)
Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study
Saeed Dabestani et al.
WORLD JOURNAL OF UROLOGY (2016)
Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour
Handoo Rhee et al.
EJNMMI RESEARCH (2016)
Follow-up After Treatment for Renal Cell Carcinoma: The Evidence Beyond the Guidelines
Paolo Capogrosso et al.
EUROPEAN UROLOGY FOCUS (2016)
Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT
Steven P. Rowe et al.
ANNALS OF NUCLEAR MEDICINE (2015)
International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality
Ariana Znaor et al.
EUROPEAN UROLOGY (2015)
Expression of Prostate-Specific Membrane Antigen in Lung Cancer Cells and Tumor Neovasculature Endothelial Cells and Its Clinical Significance
Hai-long Wang et al.
PLOS ONE (2015)
68Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma
Emre Demirci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Extracranial oligometastatic renal cell carcinoma: current management and future directions
Jasmin Loh et al.
FUTURE ONCOLOGY (2014)
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update
Cora N. Sternberg et al.
EUROPEAN JOURNAL OF CANCER (2013)
Metastatic Renal Cell Carcinoma: Radiologic Findings and Assessment of Response to Targeted Antiangiogenic Therapy by Using Multidetector CT
Blanca Pano Brufau et al.
RADIOGRAPHICS (2013)
Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET/CT in renal cell carcinoma
Hsin-Yi Wang et al.
CANCER IMAGING (2012)
Metastatic Renal Cell Carcinoma Risk According to Tumor Size
R. Houston Thompson et al.
JOURNAL OF UROLOGY (2009)
Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
Kiran Gupta et al.
CANCER TREATMENT REVIEWS (2008)
Expression of prostate-specific membrane antigen in renal cortical tumors
Hikmat A. Al-Ahmadie et al.
MODERN PATHOLOGY (2008)
Prostate-specific membrane antigen expression in regeneration and repair
Ilyssa O. Gordon et al.
MODERN PATHOLOGY (2008)
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
Bernard Escudier et al.
LANCET (2007)
Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms
Angelo Baccala et al.
UROLOGY (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Meta-analysis of the diagnostic performance of F-18-FDG pet in renal cell carcinoma
S. R. Martinez De Llano et al.
REVISTA ESPANOLA DE MEDICINA NUCLEAR (2007)
Expression of prostate-specific membrane antigen in normal and malignant human tissues
Y Kinoshita et al.
WORLD JOURNAL OF SURGERY (2006)
Molecular genetics of familial renal cell carcinoma syndromes
D Cohen et al.
CLINICS IN LABORATORY MEDICINE (2005)
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer
A Ghosh et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
The changing natural history of renal cell carcinoma
AJ Pantuck et al.
JOURNAL OF UROLOGY (2001)
Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen
SS Chang et al.
UROLOGY (2001)
Systemic therapy for renal cell carcinoma
RJ Motzer et al.
JOURNAL OF UROLOGY (2000)
Share Paper
